Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-008740
Filing Date
2022-04-12
Accepted
2022-04-12 14:19:51
Documents
1
Period of Report
2022-04-12

Document Format Files

Seq Description Document Type Size
1 CELSION OPEN MARKET PURCHASE rdgdoc.html 4  
1 CELSION OPEN MARKET PURCHASE rdgdoc.xml 4 2982
  Complete submission text file 0001437749-22-008740.txt   4537
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10220-L OLD COLUMBIA ROAD COLUMBIA MD 21046-2364
Business Address
Tardugno Michael H (Reporting) CIK: 0001384550 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 22821856